These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6537509)

  • 1. Influence of structure on the reduction of nitroxide MRI contrast-enhancing agents by ascorbate.
    Keana JF; Van Nice FL
    Physiol Chem Phys Med NMR; 1984; 16(6):477-80. PubMed ID: 6537509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
    Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC
    Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate.
    Keana JF; Pou S; Rosen GM
    Magn Reson Med; 1987 Dec; 5(6):525-36. PubMed ID: 3437813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance relaxivity of dendrimer-linked nitroxides.
    Winalski CS; Shortkroff S; Mulkern RV; Schneider E; Rosen GM
    Magn Reson Med; 2002 Dec; 48(6):965-72. PubMed ID: 12465105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates.
    Couet WR; Brasch RC; Sosnovsky G; Tozer TN
    Magn Reson Imaging; 1985; 3(1):83-8. PubMed ID: 3999940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents.
    Keana JF; Pou S
    Physiol Chem Phys Med NMR; 1985; 17(2):235-40. PubMed ID: 3001795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of nitroxides as potential contrast agents for MR imaging.
    Rosen GM; Griffeth LK; Brown MA; Drayer BP
    Radiology; 1987 Apr; 163(1):239-43. PubMed ID: 3823443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-reactivity relationship of piperidine nitroxide: electrochemical, ESR and computational studies.
    Yamasaki T; Mito F; Ito Y; Pandian S; Kinoshita Y; Nakano K; Murugesan R; Sakai K; Utsumi H; Yamada K
    J Org Chem; 2011 Jan; 76(2):435-40. PubMed ID: 21190389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast agents in magnetic resonance imaging].
    Couet W; Revel D; Devissaguet JP; Wesbey G; Brasch R
    J Radiol; 1985 May; 66(5):397-402. PubMed ID: 4032350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage.
    Krishna MC; DeGraff W; Hankovszky OH; Sár CP; Kálai T; Jeko J; Russo A; Mitchell JB; Hideg K
    J Med Chem; 1998 Aug; 41(18):3477-92. PubMed ID: 9719601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ascorbic acid-resistive nitroxide in a lipid emulsion: an efficient brain imaging contrast agent for MRI of small rodents.
    Emoto MC; Yamada K; Yamato M; Fujii HG
    Neurosci Lett; 2013 Jun; 546():11-5. PubMed ID: 23643988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nitroxide spin probes and electron paramagnetic resonance for assessing reducing power of beer. role of SH groups.
    Kocherginsky NM; Kostetski YY; Smirnov AI
    J Agric Food Chem; 2005 Feb; 53(4):1052-7. PubMed ID: 15713019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ideal imaging in MR: contrast-enhancing pharmaceuticals. Evaluation of tempo carboxylic acid as nitroxide diagnostic agent.
    Lamarque JL; Almès C; Rouanet JP; Prat X; Bruel JM; Pujol J; Rodière MJ; Martin JM; Lopez P; Rossi M
    Eur J Radiol; 1986 Feb; 6(1):48-52. PubMed ID: 3699037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of relative configuration of TEMPO-type nitroxides on ascorbate reduction.
    Azuma R; Yamasaki T; Emoto MC; Sato-Akaba H; Sano K; Munekane M; Fujii HG; Mukai T
    Free Radic Biol Med; 2023 Jan; 194():114-122. PubMed ID: 36442586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and electrochemical reduction rates of cyclic nitroxides (nitroxyls).
    Morris S; Sosnovsky G; Hui B; Huber CO; Rao NU; Swartz HM
    J Pharm Sci; 1991 Feb; 80(2):149-52. PubMed ID: 2051318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and mechanism of the comproportionation reaction between oxoammonium cation and hydroxylamine derived from cyclic nitroxides.
    Israeli A; Patt M; Oron M; Samuni A; Kohen R; Goldstein S
    Free Radic Biol Med; 2005 Feb; 38(3):317-24. PubMed ID: 15629861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the tetraethyl substituted pH-sensitive nitroxides of imidazole series with enhanced stability towards reduction.
    Kirilyuk IA; Bobko AA; Grigor'ev IA; Khramtsov VV
    Org Biomol Chem; 2004 Apr; 2(7):1025-30. PubMed ID: 15034626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tempicol-2 (4-hydroxy-4-(2-picolyl)-2,2,6,6-tetramethylpiperidine-1-oxyl), a stable free radical, is a novel member of nitroxide class of antioxidants and anticancer agents.
    Metodiewa D; Skolimowski J; Kochman A; Gwozdzinski K; Głebska J
    Anticancer Res; 1998; 18(1A):369-77. PubMed ID: 9568105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azethoxyl nitroxide spin labels. ESR studies involving thiourea crystals, model membrane systems and chromatophores, and chemical reduction with ascorbate and dithiothreitol.
    Lee TD; Birrell GB; Bjorkman PJ; Keana JF
    Biochim Biophys Acta; 1979 Feb; 550(3):369-83. PubMed ID: 217428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report.
    Brasch RC; Nitecki DE; Brant-Zawadzki M; Enzmann DR; Wesbey GE; Tozer TN; Tuck LD; Cann CE; Fike JR; Sheldon P
    AJR Am J Roentgenol; 1983 Nov; 141(5):1019-23. PubMed ID: 6605041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.